Your Cart is Empty
BUY 1 GET 1 FREE · AUTO APPLIES AT CHECKOUT
**DISCLAIMER:Kratom is not approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. The information in this article is educational in nature. Kratom carries real risks including dependence and adverse health effects. Consult a licensed healthcare professional before using kratom, especially if you have pre-existing health conditions, take medications, or are pregnant or breastfeeding.
Kratom is one of the most discussed — and most misunderstood — botanical products in America today. Millions of people use it regularly. Federal regulators have attempted to ban it. Researchers are actively studying its pharmacology. State legislatures have passed laws both prohibiting and protecting it. And yet for many people, the most basic question remains unanswered: what exactly is kratom?
This complete guide fromPureCraft CBD answers that question thoroughly — covering kratom's botanical origins, its active compounds, how it works in the body, its effects at different doses, its potential uses, its real risks, and where it stands legally. Whether you have never heard of kratom or are already a regular user, this is the most complete introduction you will find.
Kratom — scientifically known asMitragyna speciosa — is a tropical evergreen tree in the coffee family (Rubiaceae) native to Southeast Asia. It grows naturally in Thailand, Malaysia, Indonesia, Papua New Guinea, and neighboring countries, where it has been used for centuries as a traditional botanical by indigenous farming and laboring communities.
The tree can grow up to 25 meters tall and produces large, dark green leaves that contain dozens of active alkaloids — biologically active plant compounds responsible for kratom's wide range of effects. In its native regions, kratom leaves were traditionally chewed fresh or brewed into tea to combat fatigue, manage pain, and increase productivity during long work days.
In Western markets, kratom is most commonly sold as a finely ground powder made from dried, crushed leaves, as well as in capsule, extract, and liquid shot formats. ExplorePureCraft CBD's lab-tested kratom products to see the full range of available formats.
Kratom's effects are driven by its alkaloid profile — a complex mixture of more than 40 identified compounds. The two most pharmacologically significant are:
Mitragynine is the most abundant alkaloid in kratom leaf, comprising approximately 60–66% of total alkaloid content. It is a partial agonist at mu-opioid receptors and an antagonist at kappa and delta opioid receptors — a receptor profile that distinguishes it from classical opioids. Mitragynine also interacts with adrenergic, serotonergic, and dopaminergic receptor systems, explaining kratom's stimulant effects at low doses.
7-Hydroxymitragynine is present in smaller quantities (~2% of alkaloids) but is estimated to be significantly more potent at mu-opioid receptors than mitragynine — and more potent than morphine by weight in some laboratory comparisons. It is a key driver of kratom's opioid-like effects at higher doses. 7-OH-mitragynine is both a direct product of leaf alkaloid synthesis and a metabolite produced when the body converts mitragynine.
Additional alkaloids including speciociliatine, speciogynine, paynantheine, and rhynchophylline contribute to kratom's overall pharmacological profile — influencing sedation, anti-inflammatory activity, and receptor binding characteristics. This complexity is part of why kratom's effects differ from isolated pharmaceutical compounds.
Kratom's complex pharmacology involves interactions with multiple receptor systems simultaneously — which is why its effects are so dose-dependent and difficult to categorize simply.
Mitragynine and 7-hydroxymitragynine bind to mu-opioid receptors — the same receptors targeted by morphine, oxycodone, and heroin. However, kratom's alkaloids are partial agonists rather than full agonists, and they engage the receptor through a "G protein-biased" pathway that theoretically produces less respiratory depression than full opioid agonists. This is the primary mechanism behind kratom's analgesic, euphoric, and sedative effects at higher doses.
At lower doses, mitragynine activates alpha-2 adrenergic receptors — producing norepinephrine-like stimulant effects including increased energy, alertness, and focus. This is the mechanism behind kratom's traditional use as a work aid and the reason low-dose kratom feels more like a strong coffee than an opioid.
Kratom alkaloids also interact with serotonin receptors (5-HT2A) and have indirect effects on dopamine pathways — contributing to mood elevation, euphoria, and the reward-pathway activation that underlies kratom's addiction potential.
One of kratom's most distinctive and pharmacologically unusual characteristics is its dose-dependent reversal of effects. The same plant produces strikingly different experiences depending on how much is consumed:
|
Dose Range |
Predominant Effects |
Duration |
Character |
|
1–3g (Low) |
Stimulant — energy, focus, alertness, mild mood lift |
2–3 hours |
Like strong coffee; functional, clear-headed |
|
3–6g (Moderate) |
Mixed — euphoria, mild pain relief, relaxation beginning |
3–5 hours |
Warm, mood-elevating, increasingly relaxing |
|
6–10g (High) |
Opioid-like — sedation, analgesia, strong euphoria |
4–6+ hours |
Heavy, pain-relieving, cognitively impairing |
|
10g+ (Very High) |
Dominant sedation, nausea risk, adverse effects |
Variable |
Not recommended; significant risk of adverse effects |
To understand kratom fully, its cultural and historical context matters. In Thailand, Malaysia, and Indonesia, kratom has been used for hundreds — possibly thousands — of years. Traditional use included:
This traditional use context is important: the doses typically used in traditional Southeast Asian contexts (a few fresh leaves) are considerably lower than the gram-range doses common in Western powder consumption, which has implications for both effects and risks.
Kratom arrived in significant quantities in the US market in the early 2000s, initially circulating in herbal supplement shops and online retailers. Its popularity grew substantially through the 2010s, driven by word-of-mouth in communities seeking alternatives for pain management, anxiety, fatigue, and opioid withdrawal.
By the mid-2010s, estimates suggested millions of Americans were regular kratom users. The American Kratom Association — the primary consumer advocacy organization — has estimated the US kratom user base at 10–16 million people, though independent verification of this figure is difficult.
The growth in use coincided with increased regulatory scrutiny, media coverage ranging from enthusiastic to alarming, and a growing body of scientific research attempting to characterize kratom's pharmacology, benefits, and risks objectively.
Kratom is available in several formats, each with different onset times, bioavailability, and practical considerations:
•Kratom powder:The most common format. Dried leaves ground into fine powder. Usually measured by the gram and consumed via "toss and wash" (placing powder in mouth and washing down with water), mixed into beverages, or brewed as tea. Onset: 15–30 minutes
Kratom products are typically categorized by vein color — referring to the color of the central vein of the leaf at harvest, which reflects maturity and alkaloid profile:
|
Vein Color |
Alkaloid Profile |
Primary Effects |
Best For |
|
White Vein |
High mitragynine, lower 7-OH |
Stimulating, energizing, focus-enhancing |
Morning energy, productivity, daytime use |
|
Green Vein |
Balanced profile |
Moderate energy + mild relaxation |
Balanced everyday use, beginners |
|
Red Vein |
Higher 7-OH, speciociliatine |
Sedating, analgesic, deeply relaxing |
Pain relief, sleep support, evening use |
|
Yellow/Gold |
Varies (blending or drying technique) |
Balanced, mellow, smooth onset |
Moderate all-day use |
For a complete strain-by-strain breakdown, see our guide:Types of Kratom: Complete Guide to Strains, Vein Colors & Effects.
Kratom users report a wide range of reasons for use. Large-scale surveys — most notably Grundmann's 2017 study of 8,049 US kratom users — have documented the most common self-reported benefits:
For a detailed breakdown of the evidence behind each potential benefit, see:7 Potential Health Benefits of Kratom: What the Science Actually Says.
Kratom carries real risks that every prospective user should understand clearly before making any decisions.
For complete safety information:Is Kratom Safe to Use? Side Effects, Risks & Who Should Avoid It.
Kratom's legal status is one of the most frequently changing aspects of this topic. Here is the current landscape:
Kratom is federally legal in the United States — it is not classified as a controlled substance under the Controlled Substances Act. The FDA has not approved it for any medical use and has issued significant regulatory warnings, but has not successfully scheduled it. The DEA attempted emergency scheduling in 2016 but withdrew after public and scientific pushback.
Six states have banned kratom: Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin. Several cities and counties in otherwise legal states have enacted local restrictions.
A growing number of states have passed the Kratom Consumer Protection Act (KCPA) — model legislation that regulates kratom rather than banning it, establishing age limits, labeling requirements, and quality standards. KCPA states include Utah, Georgia, Arizona, Nevada, Oklahoma, and others.
For the full legal breakdown:Is Kratom Legal? Federal Status, State Laws & Where It's Banned.
No other factor shapes the kratom experience more than dose. The difference between a productive, clear-headed stimulant experience and an overwhelming opioid-like sedation can be as little as 2–3 grams. General guidance:
For complete dosage guidance:Kratom Dosage Guide: How Much to Take by Goal, Strain & Experience Level.
|
Substance |
Primary Mechanism |
Psychoactive? |
FDA Approved? |
Dependence Risk |
Legal Status (Federal) |
|
Kratom |
Partial mu-opioid agonist + adrenergic |
Yes (dose-dependent) |
No |
Yes (moderate) |
Legal (unscheduled) |
|
CBD |
ECS modulation, serotonergic |
No |
Epidiolex only (epilepsy) |
Very low |
Legal (hemp-derived) |
|
Delta-9 THC |
CB1 agonist |
Yes |
Dronabinol (nausea/appetite) |
Low-moderate |
Illegal (cannabis) / Legal (hemp ≤0.3%) |
|
Buprenorphine |
Partial mu-opioid agonist |
Mild |
Yes (OUD) |
Yes (managed medically) |
Schedule III (prescription) |
|
Morphine |
Full mu-opioid agonist |
Yes |
Yes (pain) |
High |
Schedule II (prescription) |
Not all kratom products are equal — and the quality difference carries real health implications. Unregulated kratom products have been found to contain:
This is why purchasing from vendors who provide independent, third-party Certificates of Analysis (COAs) for every batch is not optional — it is a basic safety requirement. AllPureCraft CBD kratom products are tested by accredited independent laboratories. View ourpublished lab results for complete transparency.
Kratom is a botanical supplement — a plant-derived product sold in the US as a dietary supplement. It is not classified as a controlled substance at the federal level. However, it contains pharmacologically active alkaloids that interact with opioid, adrenergic, serotonergic, and dopaminergic receptor systems, producing significant psychoactive and physiological effects. Whether one calls it a "drug" depends on definition, but it is certainly pharmacologically active and carries drug-like risks.
Kratom's alkaloids interact with opioid receptors — the same receptors targeted by morphine and heroin — but kratom is not classified as an opioid by regulatory authorities. Its alkaloids are partial (not full) opioid agonists with a biased receptor activation profile that distinguishes them from classical opioids. See:Is Kratom an Opioid?.
At low doses, kratom produces stimulant effects most people would not describe as a "high." At higher doses, it produces genuine euphoria and sedation via opioid receptor mechanisms that most users would describe as psychoactive intoxication. See:Does Kratom Get You High?.
Yes — particularly with heavy daily use. Approximately 9% of regular US users develop clinically significant dependence based on survey data. Physical withdrawal upon cessation is documented and real. See:Is Kratom Addictive?.
Mitragynine has a half-life of approximately 9–10 hours. Complete elimination from plasma takes approximately 5–7 days. In urine, kratom metabolites may be detectable for up to 1–3 weeks in heavy users. See:How Long Does Kratom Stay in Your Body?.
Standard 5 and 10-panel drug tests do not screen for kratom. Specialized kratom-specific tests exist but are rarely used in routine employment screening. See:Does Kratom Show Up On A Drug Test?.
Kratom powder has a distinctly bitter, earthy taste that many users find unpleasant. This is one reason capsules and flavored drinks are popular delivery methods. Some users mix kratom powder into orange juice, chocolate milk, or strong-flavored beverages to mask the bitterness.
Daily use is the primary risk factor for developing kratom dependence and tolerance. Most experienced users and harm reduction advocates recommend using kratom no more than 3–4 days per week, with regular tolerance breaks, to minimize dependence risk.
No. Combining kratom with alcohol significantly increases CNS depression risk, liver stress, and overdose potential. This is one of the most important kratom safety rules. See:Kratom and Alcohol: Why This Combination Is Dangerous.
Kava is a Pacific Island botanical that works through GABA receptor activity — producing relaxation and anxiety relief without opioid receptor involvement and with much lower dependence risk than kratom. They are pharmacologically distinct despite both being botanicals used for relaxation. See:Kava vs. Kratom: Key Differences in Effects, Safety & Which Is Right for You.
The KCPA is model legislation developed by the American Kratom Association that establishes age limits (18+), mandatory quality testing and labeling, prohibitions on adulterants, and vendor registration requirements. It represents a regulatory rather than prohibition approach and has been passed in several US states.
Survey data suggests US kratom users are demographically diverse, skewing slightly older (average age mid-30s to 40s), with roughly equal gender representation. Common user profiles include people managing chronic pain, former opioid users seeking alternatives, individuals managing anxiety or depression, and people seeking energy and productivity support. The user base is not primarily recreational drug seekers — the majority of users cite functional wellness goals.
CBD (cannabidiol) is a non-psychoactive hemp-derived cannabinoid that works primarily through the endocannabinoid system. Kratom is a psychoactive botanical that works primarily through opioid and adrenergic receptor systems. CBD carries no dependence risk and does not produce a "high." Kratom carries real dependence potential and produces dose-dependent psychoactive effects. They are completely different compounds with different mechanisms, effects, and risk profiles.
Kratom is a pharmacologically complex, biologically active botanical that defies simple categorization. It is not simply an herbal supplement — its alkaloids interact powerfully with opioid, adrenergic, serotonergic, and dopaminergic systems, producing effects that range from energizing stimulation to opioid-like sedation depending on dose. It has a centuries-long history of traditional use, a growing body of scientific research, millions of American users, and a genuinely complicated risk-benefit profile.
Understanding kratom accurately — not through the lens of either enthusiastic promotion or reflexive alarm — is the foundation of any responsible decision about its use. We hope this guide has provided that foundation. If you have additional questions, our full educational library covers every aspect of kratom in depth.
BrowsePureCraft CBD's full kratom collection, view ourthird-party lab results, and explore our completekratom education library. These statements have not been evaluated by the FDA. Our products are not intended to diagnose, treat, cure, or prevent any disease.
Medical Disclaimer | This article is for informational and educational purposes only. CBD is a supplement, not a medication. Advanced biohacking p...
Read More
Medical Disclaimer | This article is for informational purposes only. CBD and GABA supplements are supplements, not medications. Anxiety and sleep...
Read More
Medical Disclaimer | This article is for informational purposes only. St. John's Wort has documented severe drug interactions with numerous prescr...
Read More